ONC CLUSTER SEC Filing Analysis

Latest settled — T+5d

ONC ▼ -3.67% at T+5d

NEUTRAL call ✗ call lost -3.67% · α vs SPY -3.98% · entry $290.58 → $279.93

Next anchor: T+20d in 12d

Currently $264.48 · -8.98% from $290.58 entry

Entry anchored
May 27, 2026
via day open

T+1d

-0.92%

call -0.92% · α -1.16%

$287.92

settled 16d ago

T+5d

-3.67%

call -3.67% · α -3.98%

$279.93

settled 10d ago

T+20d

—

call — · α —

—

in 12d

T+60d

—

call — · α —

—

in 2mo

Price Chart

Loading chart...

Executive Summary

Two directors at BeOne Medicines sold a combined $131K in open-market transactions on May 22, 2026. The total value represents ~0.0004% of the $33.6B market cap — a trivial amount. Baker Bros. Advisors LP sold at $23.85/share while Sanders Corazon sold at $309.59/share, suggesting the Baker Bros. trade may involve a different share class or a data error. No C-suite insiders participated, and the dollar amounts are immaterial relative to company size.

Key Financial Metrics

Direction

selling

Total Value

$131.0K

Insiders

2

Actionable Insight

This cluster is routine and non-informative. The dollar amount is negligible, no C-suite insiders sold, and the price discrepancy between the two trades suggests a possible data anomaly rather than coordinated selling. No action warranted.

Key Facts

Two directors sold a combined $131K in open-market transactions on May 22, 2026
Baker Bros. Advisors LP sold 2,743 shares at $23.85/share ($65K)
Sanders Corazon sold 212 shares at $309.59/share ($66K)
Total sales represent ~0.0004% of ONC's $33.6B market cap
No C-suite executives (CEO/CFO) participated in the cluster
The large price discrepancy between the two trades ($23.85 vs $309.59) is unusual and may indicate a different share class or data issue

Financial Impact

Total insider sales of $131K — immaterial relative to $33.6B market cap

Risk Factors

The $23.85 vs $309.59 price gap between the two trades is unexplained and could indicate a data error or different share class

Market Snapshot

Exchange

OTC

Sector

Pharmaceutical Preparations

Analyst Consensus

93% bullish (15 analysts)

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

Document	Accession Number
CLUSTER Data (Synthetic)	cluster-ONC-1779917200443

4 reports for ONC

T+1T+5T+20T+60

Track record builds as more directional reports settle.

Filters

Reports for ONC — sortable, filterable
	Type				Now
Jun 11, 2026 1d ago	144 NEUTRAL ★ 2/10	$260.31 awaiting T+5	awaiting T+5	—	$264.48 (+1.60%)
Jun 10, 2026 2d ago	Insider Cluster NEUTRAL ★ 2/10	$263.47 awaiting T+5	awaiting T+5	—	$264.48 (+0.38%)
May 27, 2026 16d ago	Insider Cluster NEUTRAL ★ 2/10	$290.58 $279.93	▼ −3.67%	▼ −3.98%	$264.48 (−8.98%)
Feb 26, 2026 15w ago	8-K BULLISH ★ 8/10	$322.37 $292.94	▼ −9.13%	▼ −8.00%	$264.48 (−17.96%)

US Market Status

Market Closed — Opens Mon (48h 52m)

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access